Corona Beer Custom Case Solution & Analysis

1. Evidence Brief (Case Researcher)

Financial Metrics

Corona Extra sales in US: 15.9 million cases in 1986 (Exhibit 1).
Growth rate: 1985 to 1986 sales volume increased from 10.1M to 15.9M cases (Exhibit 1).
Pricing: Corona Extra retail price per six-pack roughly $5.00–$6.00 (Paragraph 12).
Importer margin: Barton Beers and Gambrinus Import Co. capture significant distribution margins (Paragraph 9–10).

Operational Facts

Supply Chain: Produced by Grupo Modelo in Mexico; imported into US by two separate regional entities (Paragraph 8–9).
Distribution: Barton covers western US; Gambrinus covers eastern US (Paragraph 9).
Marketing: Minimal spend; growth driven by word-of-mouth and image (Paragraph 14).
Inventory: Chronic shortages in 1986 due to production capacity limits at Modelo (Paragraph 18).

Stakeholder Positions

Grupo Modelo (Don Nemesio Diez): Prefers conservative, steady growth; reluctant to over-expand capacity (Paragraph 20).
US Importers (Barton/Gambrinus): Urging rapid capacity expansion to meet surging demand and capitalize on momentum (Paragraph 21).
US Retailers/Consumers: High demand, frustrated by stock-outs (Paragraph 18).

Information Gaps

Specific production capacity limits in hectoliters at Modelo plants.
Detailed cost breakdown per case (landed cost vs. wholesale price).
Long-term marketing budget commitment from importers.

2. Strategic Analysis (Strategic Analyst)

Core Strategic Question

How should Grupo Modelo balance the opportunity for rapid US market share expansion against the risk of compromising the brand equity and operational stability of its primary asset, Corona Extra?

Structural Analysis

Supply-Side Constraints: Modelo faces a hard capacity ceiling. Aggressive expansion requires massive capital expenditure which conflicts with the current conservative management philosophy.
Distribution Power: The split-importer model creates localized management but limits centralized control over US pricing and marketing consistency.
Brand Positioning: Corona success is tied to exclusivity and scarcity. Over-saturation risks commoditizing the product.

Strategic Options

Option A: Rapid Capacity Expansion. Invest heavily in new brewing facilities. Trade-offs: Captures immediate demand but risks quality control and high financial exposure if the trend reverses.
Option B: Controlled Growth/Premium Pricing. Constrain supply to maintain scarcity and increase prices. Trade-offs: Protects margins and brand image but invites competitors to fill the void.
Option C: Dual-Brand Strategy. Introduce a secondary brand to capture volume while keeping Corona premium. Trade-offs: Dilutes marketing focus and risks internal cannibalization.

Preliminary Recommendation

Pursue Option B. Maintain scarcity to sustain brand premium while incrementally increasing capacity. This preserves the high-margin, high-demand status of the brand while avoiding the financial risks of over-extending production infrastructure.

3. Implementation Roadmap (Implementation Specialist)

Critical Path

Negotiate long-term supply volume agreements with importers to standardize regional pricing.
Audit existing production lines to optimize output without full-scale expansion.
Launch selective marketing campaigns in high-margin regions to maintain brand awareness without increasing total volume demand.

Key Constraints

Capital Allocation: Modelo management resistance to debt-financed expansion.
Logistics: Inconsistent supply chain performance across the two US importers.
Market Timing: The risk that the current import-beer fad fades before capacity comes online.

Risk-Adjusted Implementation

Focus on debottlenecking current facilities (low-cost, high-yield) before committing to new plant construction. Use regional supply allocation to prioritize high-margin accounts, ensuring that when stock-outs occur, they happen in less profitable segments.

4. Executive Review and BLUF (Executive Critic)

BLUF

Corona is currently an accidental success story. The brand is winning because it is scarce, not because it is managed. Management must stop treating the US market as an afterthought. The current split-importer model is a structural liability that prevents a unified US strategy. Modelo should move to consolidate import rights or impose strict performance-based contracts that mandate shared marketing and logistics standards. Expansion should be funded by the importers, not Modelo, to align incentives. If the importers want the volume, they should carry the capital risk of the increased production requirements. If they refuse, Modelo should seek partners who will.

Dangerous Assumption

The assumption that the current US demand is sustainable long-term without active brand management. The brand is currently riding a wave; without investment, it will be replaced by the next trend.

Unaddressed Risks

Importer Conflict: The two-importer model creates zero incentive for either to invest in brand-wide infrastructure.
Quality Dilution: Rapid expansion often leads to production shortcuts which would be fatal to the Corona brand image.

Unconsidered Alternative

Acquire the US importers. Bringing distribution in-house would allow Modelo to capture the full margin and unify the brand message, eliminating the fragmented approach currently causing the supply and marketing misalignment.